MOH — authorised 17 November 2022
- Marketing authorisation holder: PROVENTION BIO INC
- Status: likely_approved
MOH authorised Tzield on 17 November 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 17 November 2022.
PROVENTION BIO INC holds the Israeli marketing authorisation.